EDITOR—For decision analysts Swensen's review of computed tomography screening is both refreshing to see and at the same time wholly unsurprising.1 The risks from false positive results are made clear even for non-quantitatively oriented clinicians, and questions are raised on other expensive screening procedures and unsubstantiated recommendations from so called medical centres of excellence.

In the United States countless companies and hospital consortia …